West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
February 15, 2024 at 06:45 AM EST
WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|